Suzanne Gagnon, MD, FACP

Dr. Gagnon has been leading the medical and safety aspects of pharmaceutical product development for more than 20 years, including senior management positions in both academia and in the Pharmaceutical and CRO industries.  She recently joined NuPathe as their Chief Medical Officer to focus on the development of products innovating Neuroscience. Before that she spent nearly 10 years as Chief Medical Officer and Executive Vice President at ICON Clinical Research where she provided strategic vision and domain expertise leadership for all Medical, Safety, Scientific, Regulatory, Risk Management and Medical Writing activities.  She oversaw a staff of 400 professionals across 10 global locations and was responsible for many global initiatives both within ICON and for clients.

She has been involved in two major safety recall programs, collaborating closely with litigation teams. She has experience in the set up and management of Drug Safety Monitoring Boards, Clinical Endpoint Committees, Global Quality Management Systems.  At ICON, Dr. Gagnon was the Chair of the Safety and Regulatory Risk Management Committee. 

She has provided consultancy in the establishment and reengineering of Pharmacovigilance Departments including providing responsible oversight of the QPPV function in Europe, low cost options in India and medical writing of aggregate safety reports and REMs in native English speaking countries.

Prior to ICON, Dr. Gagnon worked in positions of increasing responsibility in product development and Medical Affairs, in therapeutic areas including oncology, infectious diseases, cardiovascular disease (lipid lowering agents), gastrointestinal disease and blood products, hormone replacement and anesthetics.

Dr. Gagnon received her medical degree from Boston University School of Medicine and did post graduate clinical research at the University of Miami School of Medicine. She is the author or co-author of numerous publications, abstracts and book chapters, a member of the International Editorial Advisory Board on Global Clinical Trials for Elsevier Publishing, and a frequent international speaker. Currently she lectures on Pharmaceutical Product Safety and Post-Marketing Surveillance & Risk Management as an Adjunct Professor at West Chester University of Pennsylvania.